Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
Purpose. To evaluate the efficacy of intravitreal melphalan for vitreous seeds from retinoblastoma in Chinese patients. Methods. This is a retrospective review of 17 consecutive Chinese patients (19 eyes) with viable vitreous seeds from retinoblastoma. The patients received multiple intravitreal inj...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2016/4387286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560012852985856 |
|---|---|
| author | Xunda Ji Peiyan Hua Jing Li Jiakai Li Junyang Zhao Peiquan Zhao |
| author_facet | Xunda Ji Peiyan Hua Jing Li Jiakai Li Junyang Zhao Peiquan Zhao |
| author_sort | Xunda Ji |
| collection | DOAJ |
| description | Purpose. To evaluate the efficacy of intravitreal melphalan for vitreous seeds from retinoblastoma in Chinese patients. Methods. This is a retrospective review of 17 consecutive Chinese patients (19 eyes) with viable vitreous seeds from retinoblastoma. The patients received multiple intravitreal injections of 20 ug melphalan. Results. The International Classification of Retinoblastoma groups were B in 1 eye, C in 5 eyes, D in 11 eyes, and E in 2 eyes. On average, 6 injections (range: 1–15) were given to each eye at the interval of 2–4 weeks. Successful control of vitreous seeds was achieved in 16 of 19 eyes (84.21%). Globe retention was achieved in 73.68% (14/19) eyes. The patients were followed up for 27 months on average (median: 26; range: 17–42 months). There is a significant difference in response to intravitreal melphalan for cloud, spheres, and dust seeds with a median number of injections of 9, 6, and 3, respectively (P=0.003). Complications related to intravitreal melphalan included vitreous hemorrhage, cataract, salt-and-pepper retinopathy, and pupil posterior synechia. There was no case of epibulbar extension or systemic metastasis within the period of follow-up. Conclusion. Intravitreal melphalan achieved a high local control rate for vitreous seeds without extraocular extension and with acceptable toxicity in Chinese retinoblastoma patients. |
| format | Article |
| id | doaj-art-f97bf1b968584fd98ff7df6a0635dca4 |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-f97bf1b968584fd98ff7df6a0635dca42025-02-03T01:28:40ZengWileyJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/43872864387286Intravitreal Melphalan for Vitreous Seeds: Initial Experience in ChinaXunda Ji0Peiyan Hua1Jing Li2Jiakai Li3Junyang Zhao4Peiquan Zhao5Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, ChinaDepartment of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, ChinaDepartment of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, ChinaDepartment of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, ChinaDepartment of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, 56 Nanlishi Road, Xicheng District, Beijing 100045, ChinaDepartment of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, ChinaPurpose. To evaluate the efficacy of intravitreal melphalan for vitreous seeds from retinoblastoma in Chinese patients. Methods. This is a retrospective review of 17 consecutive Chinese patients (19 eyes) with viable vitreous seeds from retinoblastoma. The patients received multiple intravitreal injections of 20 ug melphalan. Results. The International Classification of Retinoblastoma groups were B in 1 eye, C in 5 eyes, D in 11 eyes, and E in 2 eyes. On average, 6 injections (range: 1–15) were given to each eye at the interval of 2–4 weeks. Successful control of vitreous seeds was achieved in 16 of 19 eyes (84.21%). Globe retention was achieved in 73.68% (14/19) eyes. The patients were followed up for 27 months on average (median: 26; range: 17–42 months). There is a significant difference in response to intravitreal melphalan for cloud, spheres, and dust seeds with a median number of injections of 9, 6, and 3, respectively (P=0.003). Complications related to intravitreal melphalan included vitreous hemorrhage, cataract, salt-and-pepper retinopathy, and pupil posterior synechia. There was no case of epibulbar extension or systemic metastasis within the period of follow-up. Conclusion. Intravitreal melphalan achieved a high local control rate for vitreous seeds without extraocular extension and with acceptable toxicity in Chinese retinoblastoma patients.http://dx.doi.org/10.1155/2016/4387286 |
| spellingShingle | Xunda Ji Peiyan Hua Jing Li Jiakai Li Junyang Zhao Peiquan Zhao Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China Journal of Ophthalmology |
| title | Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China |
| title_full | Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China |
| title_fullStr | Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China |
| title_full_unstemmed | Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China |
| title_short | Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China |
| title_sort | intravitreal melphalan for vitreous seeds initial experience in china |
| url | http://dx.doi.org/10.1155/2016/4387286 |
| work_keys_str_mv | AT xundaji intravitrealmelphalanforvitreousseedsinitialexperienceinchina AT peiyanhua intravitrealmelphalanforvitreousseedsinitialexperienceinchina AT jingli intravitrealmelphalanforvitreousseedsinitialexperienceinchina AT jiakaili intravitrealmelphalanforvitreousseedsinitialexperienceinchina AT junyangzhao intravitrealmelphalanforvitreousseedsinitialexperienceinchina AT peiquanzhao intravitrealmelphalanforvitreousseedsinitialexperienceinchina |